KR20140019536A - Cosmetic composition containing oreocnide fruticosa extraction - Google Patents

Cosmetic composition containing oreocnide fruticosa extraction Download PDF

Info

Publication number
KR20140019536A
KR20140019536A KR1020120085669A KR20120085669A KR20140019536A KR 20140019536 A KR20140019536 A KR 20140019536A KR 1020120085669 A KR1020120085669 A KR 1020120085669A KR 20120085669 A KR20120085669 A KR 20120085669A KR 20140019536 A KR20140019536 A KR 20140019536A
Authority
KR
South Korea
Prior art keywords
extract
cosmetic composition
oreocnide
fruticosa
present
Prior art date
Application number
KR1020120085669A
Other languages
Korean (ko)
Other versions
KR101441190B1 (en
Inventor
이남호
한정환
김상숙
오태헌
Original Assignee
제주대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제주대학교 산학협력단 filed Critical 제주대학교 산학협력단
Priority to KR1020120085669A priority Critical patent/KR101441190B1/en
Publication of KR20140019536A publication Critical patent/KR20140019536A/en
Application granted granted Critical
Publication of KR101441190B1 publication Critical patent/KR101441190B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a cosmetic composition containing Oreocnide fruticosa extract as an active ingredient. The Oreocnide fruticosa extract in the present invention is produced by extracting with any one low grade alcohol selected from the methanol or ethanol, and then adding hexane, ethyl acetate, butanol, and water, which have different polarities, in consecutive order to fractionate it. By the present invention, the cosmetic composition containing the Oreocnide fruticosa extract, which is effective in anti-wrinkle, anti-oxidative activity, anti-inflammatory activity, and skin whitening, as the active ingredient.

Description

비양나무 추출물을 포함하는 화장료 조성물{Cosmetic composition containing Oreocnide fruticosa extraction}[0001] The present invention relates to a cosmetic composition containing oleic acid fruticosa extract,

본 발명은 비양나무 추출물을 유효성분으로 포함하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition comprising an extract of Opuntia as an active ingredient.

인간 노화의 근본적인 원인을 해결하고자 현대과학에서는 다양한 방법으로 그 연구를 진행하고 있으며 삶이 점점 윤택해지면서 신체의 내적인 노화뿐만 아니라 외적인 부분에 발생하는 노화를 막고자 하는 관심이 증대되고 있다. 특히, 인간의 외적 노화 연구에서는 피부를 이용해서 많은 연구가 진행되고 있다.In order to solve the fundamental cause of human aging, modern science is conducting research in various ways. As life becomes more and more rich, there is increasing interest to prevent aging which occurs in the external part as well as internal aging of the body. Especially, in the research on the external aging of human beings, many studies using skin have been carried out.

피부의 노화에는 시간이 경과함에 따라 기관과 동반하여 피부의 구조와 기능이 지속적으로 감퇴되는 내인성노화(Chronologic aging)와 장기간에 걸친 태양광선의 노출로 인한 피부조직의 변화인 외인성노화(Photoaging)가 있다. 이러한 노화 과정으로 피부가 건조해지면서, 주름이 생기고 피부는 탄력을 잃게 된다.Chronologic aging in which the structure and function of the skin is continuously decreased with aging as the time elapses, and extrinsic aging (photoaging), which is a change in the skin tissue due to long-term exposure of the sun's rays have. This aging process causes the skin to dry out, wrinkles, and the skin to lose its elasticity.

피부노화에 관한 연구에서 가장 중요하게 다루어지는 것은 자유 라디칼(free radical)과 활성산소종(Reactive oxigen species)이다. 이들은 자연적으로 생체 내에서 만들어지기도 하지만 공해, 태양 자외선, 화학 산화제 및 미생물 등에 의해 발생된다. 이때 발생된 자유전자나 활성산소종은 피부세포에 산화적 스트레스를 가하게 되고, 이러한 과정에서 생긴 물질은 멜라닌과 주름 생성의 원인물질로 여겨진다. 이들 활성 산소종은 효소적, 비효소적 항산화제로 이루어진 피부 항산화 방어막을 붕괴시키고 생체분자의 산화적 변형, 피부 장벽의 손상과 결합조직인 콜라겐, 히아루론산 등의 사슬절단 및 비정상적인 교차결합에 의한 주름생성 등 피부노화를 가속 시킨다.Free radicals and reactive oxygen species are the most important treatments in skin aging research. They are naturally produced in vivo but are caused by pollution, sunlight, chemical oxidants and microorganisms. The free electrons and reactive oxygen species generated in this process induce oxidative stress on the skin cells, and the substances generated during this process are considered to be the causative agents of melanin and wrinkle formation. These active oxygen species disrupt skin antioxidant defense membranes composed of enzymatic and non-enzymatic antioxidants, oxidative deformation of biomolecules, damage of skin barrier and chain breaks such as collagen and hyaluronic acid which are connective tissues, and wrinkle formation by abnormal cross-linking Accelerate skin aging.

한편, 멜라닌 생성 혹은 멜라노사이트의 증식에 의해 야기되는 색소 침착은 다양한 방법으로 억제가 가능하다. 일반적으로는 멜라닌합성의 중요한 효소인 티로시나제(Tyrosinase) 활성억제, 멜라노사이트의 기능감소, 자동산화 반응의 억제를 통한 멜라닌 생성의 감소, 홍반과 같은 염증반응 억제 등 다양한 경로를 이용할 수 있다.On the other hand, pigmentation caused by melanin production or melanocyte proliferation can be inhibited by various methods. In general, various pathways such as suppression of tyrosinase activity, an important enzyme of melanin synthesis, reduction of melanocyte function, reduction of melanin production through inhibition of autoxidation, and suppression of inflammatory reaction such as erythema can be used.

결과적으로 피부노화 방지를 위해서는 과잉의 활성 산소종 생성을 억제하고 또한 생성된 활성산소를 효율적으로 제거할 수 있어야 하며, 피부의 주름을 일으키는 효소들의 억제, 색소침착을 진행하는 효소의 활성억제 등에 관한 연구가 필요하다. As a result, in order to prevent aging of the skin, it is necessary to inhibit the production of excess active oxygen species and to efficiently remove the generated active oxygen, to inhibit enzymes that cause skin wrinkles, Research is needed.

한국등록특허 제10-0874115호에는, 항산화효과, 피부노화 방지효과, 피부주름 개선효과, 미백효과를 갖는 백리향 추출물을 포함한 화장료 조성물에 관하여 개시되어 있다.Korean Patent Registration No. 10-0874115 discloses a cosmetic composition containing an extract of thyme having an antioxidative effect, a skin aging-preventing effect, a skin wrinkle-improving effect, and a whitening effect.

한국등록특허공보 제10-0863267호에는, 인삼, 황기, 감초, 흑축, 녹차 및 알로에 추출물을 유효성분으로 포함하여 미백효과, 피부탄력 및 주름개선 효능을 갖는 피부 개선용 조성물이 개시되어 있다.Korean Patent Registration No. 10-0863267 discloses a composition for improving skin having a whitening effect, a skin elasticity and a wrinkle-reducing effect, which comprises ginseng, hwanggi, licorice, black shaft, green tea and aloe extract as an active ingredient.

상기와 같이 여러 식물에 대한 연구가 시행되고 있으나, 아직까지 비양나무를 이용한 화장료 조성물에 대한 연구는 시행된 바가 없다.
Studies on various plants have been conducted as described above. However, research on the cosmetic compositions using non-sapwood has not yet been conducted.

비양나무(Oreocnide fruticosa)는 원산지가 한국이며, 우리나라 비양도 및 일본의 규슈, 시코쿠 등지에 자생한다. 비양나무는 바위모시라고도 하며 쐐기풀과인 낙엽관목으로 줄기는 곧추서서 2 m 정도 자란다. 작은 가지는 가늘고 암자색을 띠며, 어린 가지에는 가는 털이 있다. 잎은 어긋나며 긴 타원모양으로 가장자리에 톱니가 있고 잎의 끝부분은 꼬리처럼 길어진다. 잎의 뒷면에는 어릴 때는 털이 있어 흰색을 띠고 잎의 앞면과 뒷면의 맥 위에 털이 있다. 꽃은 이른 봄에 피며 암수 딴 그루이다. Oreocnide fruticosa is native to Korea, native to Korea, Kyushu, and Shikoku in Japan. It is also known as rock boletus, which is a nettle and a deciduous shrub. The stem stands upright and grows about 2 m. The small branches are thin and dark purple, and the young branches have thin hairs. Leaves are alternate phyllotaxis, long elliptical shape with sawtooth on the edge, and the tip of the leaf is long like a tail. On the back side of the leaves, there are hairs at the time of childhood, white, with hairs on the front and back veins of the leaves. The flowers bloom in early spring and are a mature tree.

본 발명의 발명자들은 청정지역인 제주도 자생식물을 이용해서 산화작용을 차단하고, 산화 작용에 의해 유발되는 노화작용을 지연시키며, 피부의 색소 침착을 억제하기 위한 성분을 찾기 위하여 여러 제주 자생식물을 연구한 결과, 상기와 같은 효능을 가진 비양나무에서 우수한 항산화활성 효과, 주름 개선 및 탄력 증진 효과뿐만 아니라 미백효과가 있음을 확인하였다. 이러한 우수한 활성을 갖는 비양나무 추출물은 기능성 화장품 원료로의 응용이 가능하며, 천연식물을 사용함으로써 합성원료들로 야기되는 알러지 및 부작용, 안전성 및 안정성 면을 해결할 수 있음을 확인함으로써 본 발명을 완성하였다.
The inventors of the present invention conducted researches on various Jeju native plants in order to find out the ingredients for inhibiting oxidative action, delaying the aging action induced by oxidative action, and inhibiting pigmentation of skin by using native plants of Jeju Island, which is a clean area As a result, it was confirmed that there is an excellent antioxidant activity effect, wrinkle improvement and elasticity enhancement effect as well as a whitening effect in the above-mentioned Solanaceae. The present invention has been accomplished by confirming that it is possible to apply this extract as a raw material for functional cosmetics and solve allergy, side effects, safety and stability caused by synthetic raw materials by using natural plants .

한국등록특허공보 제10-0874115호Korean Patent Registration No. 10-0874115 한국등록특허공보 제10-0863267호Korean Patent Registration No. 10-0863267

본 발명은 자유 라디칼(free radical) 소거능, 항염활성 및 멜라닌 합성(melanogenesis) 저해효과를 갖는 비양나무 추출물(Oreocnide fruticosa)을 포함하여 피부주름개선, 항산화활성, 항염활성 및 피부미백효과를 갖는 화장료 조성물을 제공하고자 한다.The present invention is a free radical (free radical) scavenging, biyang tree extract having anti-inflammatory activity and melanin synthesis (melanogenesis) inhibition effect (Oreocnide antioxidant activity, anti-inflammatory activity, and skin whitening effect, including skin, hair, and fruticosa .

본 발명은 비양나무(Oreocnide fruticosa) 추출물을 유효성분으로 포함하는 화장료 조성물을 제공한다.The present invention provides a cosmetic composition comprising an extract of Oreocnide fruticosa as an active ingredient.

본 발명의 비양나무 추출물(Oreocnide fruticosa)을 유효성분으로 포함하는 화장료 조성물은 피부주름개선, 항산화활성, 항염활성 및 피부미백효과를 갖는다.The Oreocinide extract of the present invention fruticosa ) as an active ingredient has the effects of improving skin wrinkles, antioxidant activity, anti-inflammatory activity and skin whitening effect.

도 1은 B16-F10 세포배양 시스템에서 멜라닌 합성 저해효과를 나타낸 그래프이다.
도 2는 MTT 방법에 의한 세포독성를 나타낸 그래프(인간 섬유아세포(Normal human fibroblast))이다.
도 3은 MTT 방법에 의한 세포독성를 나타낸 그래프(인간 각질세포(human keratinocyte cell))이다.
도 4는 RAW 264.7 세포배양 시스템에서 멜라닌 합성 저해효과를 나타낸 그래프이다.
1 is a graph showing the inhibitory effect on melanin synthesis in the B16-F10 cell culture system.
2 is a graph showing cytotoxicity by the MTT method (normal human fibroblast).
Fig. 3 is a graph showing cytotoxicity by the MTT method (human keratinocyte cell).
FIG. 4 is a graph showing inhibitory effect on melanin synthesis in the RAW 264.7 cell culture system. FIG.

본 발명은 비양나무 추출물을 유효성분으로 포함하는 화장료 조성물을 제공한다.The present invention provides a cosmetic composition comprising an alopecific tree extract as an active ingredient.

본 발명은 상기의 비양나무를 추출하여, 피부주름개선, 항산화활성, 항염활성 및 피부미백효과를 확인하였다.
The present invention extracts the above-mentioned Mannitol, and confirmed skin wrinkles, antioxidant activity, anti-inflammatory activity and skin whitening effect.

비양나무 가지를 메탄올 또는 에탄올 중에서 선택되는 어느 하나의 저급알콜로 추출한 후 이에 극성이 다른 용매를 넣고 순차적으로 분획하여 제조하는 비양나무 추출물의 제조방법을 제공한다. The present invention provides a method for preparing a Solanum tuberosus extract, which comprises extracting Solanum tuberosum with one of lower alcohols selected from methanol or ethanol, adding a solvent having a different polarity, and sequentially fractionating the solvent.

저급 알코올과 극성이 다른 용매로는 헥산, 에틸아세테이트, 부탄올, 물 등을 사용할 수 있으나 이에 제한되는 것은 아니다.As the solvent having a polarity different from that of the lower alcohol, hexane, ethyl acetate, butanol, water and the like can be used, but it is not limited thereto.

상기 저급 알코올 추출 단계는 비양나무 가지 중량의 약 20 내지 30 배 부피의 용매를 사용하여 2 내지 3회 반복 추출하고, 여과한 후 이 여액을 감압 건조하여 분말형태로 제조하여 사용할 수 있다.
The lower alcohol extraction step may be repeated 2-3 times using a solvent having a volume of about 20 to 30 times the weight of the tree trunks, filtered, and dried under reduced pressure to prepare a powder.

본 발명은 상기의 비양나무 추출물들이 DPPH(1,1-Diphenyl-2-picrylhydrazyl radical)법을 이용한 피부 노화의 원인 물질인 자유라디칼(Free radical)의 소거 활성을 나타낸다는 것을 확인하였으며, 특히 에틸아세테이트 분획추출물과 부탄올 분획추출물에서 높은 활성을 나타냄을 확인하였다. The present inventors have found that the above-mentioned extracts of the Propolis extract exhibit the scavenging activity of free radicals, which is a causative substance of skin aging using the 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) Fraction extract and butanol fraction extract showed high activity.

또한, 비양나무 추출물에 대한 세포내에서의 미백효과를 측정하기 위하여 B16-F10 세포배양 시스템을 이용한 멜라닌 합성(melanogenesis) 저해효과를 측정한 결과, 비양나무 추출물에서 높은 멜라닌합성 저해율을 나타냄을 확인하였다.In addition, in order to measure intracellular whitening effect on the Solanum tuberculosis extract, the melanogenesis inhibition effect of the B16-F10 cell culture system was measured, and it was confirmed that the inhibition rate of melanin synthesis was high in the Solanum tuberosum extract .

이는 대조군으로 사용한 1 mg/mL의 알부틴(arbutin)의 저해율 보다도 우수한 활성을 보여 흑색종 세포(melanoma cell)내에서의 미백활성은 알부틴(arbutin)보다 우수함을 알 수 있었다. It was found that the inhibitory activity of arbutin at 1 mg / mL was better than that of arbutin, and that the whitening activity in melanoma cells was superior to that of arbutin.

또한, 비양나무 추출물에 대한 세포내에서의 항염효과를 측정하기 위하여 RAW 264.7 세포배양 시스템을 이용한 NO(Nitric oxide) 저해효과를 측정한 결과, 비양나무 추출물에서 높은 NO 저해율을 나타냄을 확인하였다. 여기서 NO(Nitric oxide)는 염증 유발에 중요한 역할을 하는 것으로 알려진 물질이다.In addition, the inhibitory effect of NO (nitric oxide) on the RAW 264.7 cell culture system was examined to determine the anti - inflammatory effect of the extract on the extract. Here, NO (nitric oxide) is a substance known to play an important role in inflammation induction.

또한, 본 발명인 비양나무 추출물들의 세포독성을 확인하기 위해 MTT 방법으로 확인한 결과, B16 흑색종 세포(melanoma cell)와 인간 섬유아세포(normal human fibroblast cell, NHF), 인간 각질세포(human keratinocyte cell)에 대한 세포독성이 거의 없음을 확인하였다.
In order to confirm the cytotoxicity of the extracts of Bombyx mori, the extracts of Bombyx mori were investigated by MTT method. As a result, B16 melanoma cells, normal human fibroblast cells (NHF) and human keratinocytes It was confirmed that there was almost no cytotoxicity to the cells.

본 발명의 비양나무 추출물은 항산화활성효과, 피부주름 개선효과, 피부미백효과가 탁월하여 식품첨가제, 음료조성물, 기능성 건강식품, 화장료조성물 등에 매우 유용하게 이용될 수 있다.INDUSTRIAL APPLICABILITY The extract of the present invention can be effectively used for food additives, beverage compositions, functional health foods, cosmetic compositions and the like because of its excellent antioxidant activity, skin wrinkle improving effect and skin whitening effect.

특히, 본 발명의 비양나무 추출물을 화장료 조성물의 유효성분으로 포함하여 사용될 시, 화장료 조성물 전체중량 대비 0.0001 내지 10.0 중량 %가 포함될 수 있고, 0.001 내지 10.0 중량 % 또는 0.1 내지 10.0 중량 % 포함될 수 있다.In particular, 0.0001 to 10.0% by weight, 0.001 to 10.0% by weight, or 0.1 to 10.0% by weight of the total composition of the cosmetic composition may be included in the cosmetic composition when it is used as an active ingredient of the cosmetic composition.

상기 추출물의 함량이 0.0001 중량% 미만인 경우에는 주름개선, 항산화활성 및 피부미백효과가 나타나지 않으며, 10 중량 % 이상인 경우에는 포함량 증가에 대한 효과 증대 정도가 미미하며, 제형상의 안정 및 안정성에 문제가 있으며 경제적이지도 못하다.When the content of the extract is less than 0.0001% by weight, wrinkle improvement, antioxidative activity and skin whitening effect are not exhibited. When the content of the extract is 10% by weight or more, the effect of increasing the content of the extract is insignificant, And it is not economical.

또한, 본 발명의 화장료 조성물은 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 보다 상세하게는, 화장수, 에센스, 로션, 크림, 팩, 파운데이션, 젤, 연고 또는 스프레이의 제형으로 제조될 수 있다.In addition, the cosmetic composition of the present invention can be prepared in any formulations which are conventionally prepared, and more specifically, it can be formulated into lotions, essences, lotions, creams, packs, foundations, gels, ointments or sprays .

또한, 약학적 조성물로 이용할 수 있으며, 약제학적 분야에서의 공지의 방법에 의해 제조될 수 있고, 그 자체 또는 약학적으로 허용되는 담체, 부형제, 희석제 등과 혼합하여 분말, 과립, 정제, 캡슐제 또는 주사제 등의 제형으로 제조되어 사용될 수 있고, 이들은 경구 또는 비경구로 투여될 수 있다.It may also be used as a pharmaceutical composition and may be prepared by known methods in the pharmaceutical field and may be prepared by mixing with itself or a pharmaceutically acceptable carrier, excipient, diluent or the like to give a powder, granule, tablet, Injections, and the like, and they can be administered orally or parenterally.

본 발명에 따른 비양나무 추출물의 유효 투여량은 체내에서 활성성분의 흡수도, 불활성화율 및 배설속도, 환자의 연령, 성별 및 상태, 치료할 질병의 중증 정도 등에 따라 적절히 선택될 수 있다.
The effective dose of the mulberry tree extract according to the present invention can be appropriately selected according to the degree of absorption, inactivation rate and excretion rate of the active ingredient in the body, age, sex and condition of the patient, severity of the disease to be treated,

이하, 본 발명의 이해를 돕기 위하여 실시예를 들어 상세하게 설명하기로 한다. 다만 하기의 실시예는 본 발명의 내용을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. 본 발명의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail with reference to the following examples. However, the following examples are intended to illustrate the contents of the present invention, but the scope of the present invention is not limited to the following examples. Embodiments of the present invention are provided to more fully describe the present invention to those skilled in the art.

<< 실시예Example 1> 본 발명의  1> of the present invention 비양나무Illiterate tree 추출물 제조 Extract preparation

비양나무(Oreocnide fruticosa) 가지는 한라수목원에서 제공받아 준비하였다. Oreocnide fruticosa ) were prepared and supplied by Halla Arboretum.

준비한 비양나무 가지 1 kg을 잘게 자른 후, 이를 70 % 에탄올 20 ℓ에 넣고 일주일 동안 침적시킨 후 여과하였다. One kilogram of the prepared yolk was cut into small pieces and placed in 20 liters of 70% ethanol for one week, followed by filtration.

여과하여 걸러진 이 여액을 감압 건조하여 분말형태인 비양나무 에탄올 추출물을 준비하였다.
The filtrate was filtered and dried under reduced pressure to prepare a powder of a non-ethanolic ethanol extract.

<< 실시예Example 2> 본 발명의  2> of the present invention 비양나무Illiterate tree 추출물 제조 Extract preparation

비양나무(Oreocnide fruticosa) 가지는 한라수목원에서 제공받아 준비하였다. Oreocnide fruticosa ) were prepared and supplied by Halla Arboretum.

준비한 비양나무 가지 1 kg을 잘게 자른 후, 이를 70 % 에탄올 20 ℓ에 넣고 일주일 동안 침적시킨 후 여과하였다. One kilogram of the prepared yolk was cut into small pieces and placed in 20 liters of 70% ethanol for one week, followed by filtration.

상기 여과하여 걸러진 이 여액에 극성이 다른 용매인 헥산, 에틸아세테이트, 부탄올, 물을 넣고 순차적으로 분획하여 생성된 분획추출물 중 헥산 분획추출물을 감압 건조하여 분말형태인 비양나무 헥산분획추출물을 준비하였다.
The hexane, ethyl acetate, butanol, and water, which are different in polarity, were sequentially added to the filtered filtrate, and the hexane fraction extract was dried under reduced pressure to prepare a powder of the octane tree hexane fraction.

<< 실시예Example 3> 본 발명의  3> of the present invention 비양나무Illiterate tree 추출물 제조 Extract preparation

실시예 2와 같은 방법으로 제조하되, 분획추출물 중 에틸아세테이트 분획추출물을 감압 건조하여 분말형태인 비양나무 에틸아세테이트 분획추출물을 준비하였다.
The ethyl acetate fraction extract in the fraction extract was dried in the same manner as in Example 2, and the fraction was extracted with ethyl acetate.

<< 실시예Example 4> 본 발명의  4> of the present invention 비양나무Illiterate tree 추출물 제조 Extract preparation

실시예 2와 같은 방법으로 제조하되, 분획추출물 중 부탄올 분획추출물을 감압 건조하여 분말형태인 비양나무 부탄올 분획추출물을 준비하였다.
The butanol fraction extract of the fraction extract was prepared by the same method as in Example 2, and then dried under reduced pressure to prepare a powder of the non-canola bean fraction.

<< 실시예Example 5> 본 발명의  5> 비양나무Illiterate tree 추출물 제조 Extract preparation

실시예 2와 같은 방법으로 제조하되, 분획추출물 중 물 분획추출물을 감압 건조하여 분말형태인 비양나무 물 분획추출물을 준비하였다.
The water fraction extract in the fraction extract was prepared by the same method as in Example 2, and then dried under reduced pressure to prepare a water fraction extract of Frecklewood.

<< 실시예Example 6>  6> 비양나무Illiterate tree 추출물이 포함된  Extracted 화장료Cosmetics 조성물의 제조 Preparation of the composition

통상적인 화장료 조성물에 화장료 조성물 전체중량대비 실시예 3 내지 5의 화장료 조성물 10 중량% 첨가하여 사용하였다.
The cosmetic composition of Examples 3 to 5 was added in an amount of 10% by weight based on the total weight of the cosmetic composition.

<< 실시예Example 7>  7> DPPHDPPH 법을 이용한 자유 Freedom by law 라디칼Radical 소거활성 측정실험 Measurement of scavenging activity

1. 실험방법1. Experimental Method

자유 라디칼 소거 활성 측정을 위해 0.2 mM DPPH를 메탄올에 용해시키고, 여기에 각 시료들을 첨가한 후, microplate reader로 517nm에서 흡광도를 측정하였다. For measurement of free radical scavenging activity, 0.2 mM DPPH was dissolved in methanol, each sample was added thereto, and the absorbance at 517 nm was measured with a microplate reader.

시료를 넣지 않은 경우를 대조군으로 하고 시료를 넣은 것(실시예 1, 2, 3, 4, 5의 추출물)을 실험군으로 하여 저해율을 측정하였다. The inhibition rate was measured using the test sample in which no sample was added as a control group (extracts of Examples 1, 2, 3, 4 and 5) as experimental groups.

소거 활성은 DPPH의 농도가 50% 감소되는데 필요한 시료의 농도(free radical scavenging activity: SC50, μg/mL)로 표시하였다. The scavenging activity was expressed as the concentration of free radical scavenging activity (SC 50 , μg / mL) required to reduce the concentration of DPPH by 50%.

프리라디칼 소거능(%)식은 아래와 같다.The free radical scavenging ability (%) is as follows.

= [1-(A-A')/(B-B')]×100= [1- (A-A ') / (B-B')] 100

A: 시료를 첨가한 반응용액의 517nm에서 흡광도A: absorbance at 517 nm of the reaction solution to which the sample was added

A': DPPH를 첨가하지 않은 반응용액의 517nm에서 흡광도A ': absorbance at 517 nm of the reaction solution without addition of DPPH

B: 시료를 첨가하지 않은 반응용액의 517nm에서 흡광도B: Absorbance at 517 nm of the reaction solution to which no sample was added

B': 시료와 DPPH를 첨가하지 않은 반응용액의 517nm에서 흡광도
B ': Absorbance at 517 nm of the reaction solution without addition of the sample and DPPH

2. 실험결과2. Experimental results

상기 실험결과, 아래의 표 1과 같이 나타났다.The results of the experiment are shown in Table 1 below.

SC50(μg/mL)SC 50 (μg / mL) 실시예 1(EtOH)Example 1 (EtOH) 45.745.7 실시예 2(Hex)Example 2 (Hex) 360.5360.5 실시예 3(EtOAc)Example 3 (EtOAc) 24.824.8 실시예 4(BuOH)Example 4 (BuOH) 28.028.0 실시예 5(Water)Example 5 (Water) 122.8122.8

상기 표 1에 나타나 있듯이, 실시예 1의 추출물(에탄올 추출)의 SC50는 45.7 μg/mL, 실시예 2의 추출물(헥산 분획)은 360.5 μg/mL, 실시예 3의 추출물(에틸아세테이트 분획)은 24.8 μg/mL, 실시예 4의 추출물(부탄올 분획)은 28.0 μg/mL, 실시예 5의 추출물(물 분획)은 122.8 μg/mL로 나타남을 확인하였다.As shown in Table 1, the SC 50 of the extract (ethanol extract) of Example 1 was 45.7 μg / mL, the extract (hexane fraction) of Example 2 was 360.5 μg / mL, the extract of Example 3 (ethyl acetate fraction) , The extract (butanol fraction) of Example 4 was 28.0 μg / mL, and the extract (water fraction) of Example 5 was 122.8 μg / mL.

이에, 본 발명의 추출물 모두에게 자유 라디칼 소거활성이 나타났으며, 특히 실시예 3, 4의 추출물에서 높은 활성을 나타냄을 알 수 있었다.
Thus, all of the extracts of the present invention showed free radical scavenging activity, and in particular, the extracts of Examples 3 and 4 showed high activity.

<< 실시예Example 8> 본 발명인  8> 비양나무Illiterate tree 추출물의 멜라닌 합성 저해효과 측정실험 Experiments on the inhibitory effect of melanin synthesis on the extract

1. 실험방법1. Experimental Method

비양나무 추출물에 대한 세포내에서의 미백효과를 측정하기 위하여 B16 멜라노마 세포를 이용하여 멜라노제네시스 저해효과를 측정하였다. Melanogenesis inhibitory effect of B16 melanoma cells was measured in order to measure intracellular whitening effect on the extract of.

6 well plate에 5 × 104 cells/mL이 되도록 세포를 분주하고, 37℃의 5% CO2 조건하에서 24 h 배양 후 배지를 제거하였다. Cells were seeded at 5 × 10 4 cells / mL in a 6-well plate and cultured for 24 h at 37 ° C under 5% CO 2 .

D-phosphate buffered saline(D-PBS)으로 세척한 후 1μM α-MSH를 포함하는 배지로 교환 후 시료 추출물(실시예 1,2,3,4,5)을 농도별로 각각 첨가하여 3일간 배양하였다. After washing with D-phosphate buffered saline (D-PBS) and exchanging with medium containing 1 μM α-MSH, the sample extracts (Examples 1, 2, 3, 4 and 5) were added for each concentration and cultured for 3 days .

3일 동안 배양 후 배지를 제거한 후 D-PBS buffer로 세척한 후 트립신으로 처리하여 세포를 회수하였다. After culturing for 3 days, the medium was removed, washed with D-PBS buffer, and treated with trypsin to recover the cells.

회수된 세포는 1M NaOH 500 ㎕를 첨가하고 55℃에서 2시간 방치하여 세포내의 멜라닌을 얻었다. The recovered cells were added with 500 μl of 1M NaOH and left at 55 ° C for 2 hours to obtain intracellular melanin.

이는 microplate reader기로 475nm에서 흡광도를 측정하였다.The absorbance was measured at 475 nm using a microplate reader.

대조군으로는 알부틴(arbutin)을 사용하였다.
As a control group, arbutin was used.

2. 실험결과2. Experimental results

상기 실험결과, 도 1과 아래의 표 2, 3에 나타내었다.The results of the experiment are shown in FIG. 1 and Tables 2 and 3 below.

처리농도
(㎍/ml)
Treatment concentration
(占 퐂 / ml)
멜라닌
생합성 억제율(%)
Melanin
Biosynthesis inhibition rate (%)
세포 생존율
(%)
Cell survival rate
(%)
ControlControl 100100 00 100100 알부틴Arbutin 10001000 68.268.2 103103 실시예 1(EtOH)Example 1 (EtOH) 100100 30.630.6 68.168.1 실시예 3(EtOAc)Example 3 (EtOAc) 100100 80.680.6 101.2101.2 실시예 4(BuOH)Example 4 (BuOH) 100100 29.929.9 102.5102.5 실시예 5(water)Example 5 (water) 100100 14.814.8 104.3104.3

처리농도
(㎍/ml)
Treatment concentration
(占 퐂 / ml)
멜라닌
생합성 억제율(%)
Melanin
Biosynthesis inhibition rate (%)
세포 생존율
(%)
Cell survival rate
(%)
ControlControl 100100 00 100100 알부틴Arbutin 10001000 68.368.3 83.983.9 실시예 3(EtOAc)Example 3 (EtOAc) 25
50
100
25
50
100
-6.5
39.5
71.9
-6.5
39.5
71.9
116.7
80.1
101.2
116.7
80.1
101.2
실시예 4(BuOH)Example 4 (BuOH) 50
100
200
50
100
200
29.5
36.4
57.6
29.5
36.4
57.6
113.0
91.3
84.4
113.0
91.3
84.4

상기 표 2, 3와 도 1에 나타나 있듯이, B16 멜라노마 세포를 이용하여 세포 내에서의 미백효과를 측정하였다.As shown in Tables 2 and 3 and FIG. 1, intracellular whitening effect was measured using B16 melanoma cells.

실시예 1의 추출물(에탄올 추출)의 경우 100μg/ml에서 30.6%의 저해율을 보였고, 100μg/ml의 실시예 2의 추출물(헥산 분획)과 실시예 3의 추출물(에틸아세테이트 분획), 실시예 4의 추출물(부탄올 분획)에서 각각 97%, 80.6%, 29.9%의 멜라닌 합성 저해율을 나타냈다.The extract of Example 1 (ethanol extract) showed an inhibition rate of 30.6% at 100 μg / ml, the extract of Example 2 (hexane fraction), the extract of Example 3 (ethyl acetate fraction) and the extract of Example 4 (Butanol fraction) showed inhibition rates of melanin synthesis of 97%, 80.6% and 29.9%, respectively.

이는 대조군으로 사용한 1000 μg/ml의 알부틴(arbutin)의 저해율보다 좋은 활성정도를 보여 멜라노마 세포 내에서의 미백 활성은 알부틴보다 우수함을 알 수 있었다. It was shown that the activity of albumin was better than that of arbutin (1000 μg / ml), which was used as a control, indicating that whitening activity in Melanoma cells is superior to that of arbutin.

또한 실시예 3의 추출물(Ethyl acetate분획)은 B16 멜라노마 세포에 대한 세포독성도 적어 미백관련 화장품 소재로의 개발이 가능할 것으로 사료된다.
In addition, the extract of Example 3 (Ethyl acetate fraction) is thought to be able to be developed as a whitening-related cosmetic material because of its low cytotoxicity against B16 melanoma cells.

<< 실시예Example 9> 본 발명인  9> 비양나무Illiterate tree 추출물의 MTT 방법에 의한 세포독성 평가 실험 Evaluation of cytotoxicity by MTT method of extract

1. 실험방법1. Experimental Method

B16F10 멜라노마 세포와 인간 섬유아세포(normal human fibroblaste, NHF), 인간 각질세포(human keratinocyte cell, HKC)를 24시간 배양 후 시료 추출물(실시예 1,2,3,4,5)들을 여러 농도별로 처리한 후 2일간 배양 후 500μg/ml MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide)를 well 당 20㎕를 첨가하였다. 37℃에서 4시간 동안 반응 시킨 후 MTT 용액을 제거하고 well 당 DMSO 200㎕를 첨가하였다. 살아있는 세포와 반응하여 생긴 formazan 침전물을 용해시킨 다음 microplate reader로 540nm에서 흡광도를 측정하였다.
B16F10 melanoma cells, normal human fibroblasts (NHF), human keratinocyte cells (HKC) were cultured for 24 hours, and then the sample extracts (Examples 1, 2, 3, 4 and 5) After the treatment, the cells were cultured for 2 days, and then 20 μl of 500 μg / ml MTT (3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyl-2H-tetrazolium bromide) was added. After reacting at 37 ° C for 4 hours, the MTT solution was removed and 200 μl of DMSO was added per well. The formazan precipitate formed by the reaction with living cells was dissolved and then the absorbance was measured at 540 nm with a microplate reader.

2. 실험결과2. Experimental results

상기 실험결과를 아래의 표 2, 3, 4, 5와 도 2에 나타내었다.The experimental results are shown in Tables 2, 3, 4, 5 and 2 below.

처리농도
(㎍/ml)
Treatment concentration
(占 퐂 / ml)
NHF cell 생존율 (%)NHF cell survival rate (%) HKC 생존율
(%)
HKC survival rate
(%)
ControlControl 100100 100100 100100 실시예 1(EtOH)Example 1 (EtOH) 100100 81.381.3 70.170.1 실시예 2(Hex)Example 2 (Hex) 100100 77.577.5 62.962.9 실시예 3(EtOAc)Example 3 (EtOAc) 100100 195.3195.3 162.3162.3 실시예 4(BuOH)Example 4 (BuOH) 100100 134.6134.6 116.8116.8 실시예 5(water)Example 5 (water) 100100 123.1123.1 121.9121.9

처리농도
(㎍/ml)
Treatment concentration
(占 퐂 / ml)
NHF cell 생존율 (%)NHF cell survival rate (%)
ControlControl 100100 100100 실시예 1(EtOH)Example 1 (EtOH) 25
50
100
200
300
25
50
100
200
300
114.5
89.8
98.4
78.6
100.1
114.5
89.8
98.4
78.6
100.1
실시예 3(EtOAc)Example 3 (EtOAc) 25
50
100
200
300
25
50
100
200
300
123.6
136.1
204.9
207.3
191.5
123.6
136.1
204.9
207.3
191.5

상기 표 2, 3, 4, 5와 도 1, 2, 3에 나타나 있듯이, 인간 섬유아세포(Normal human fibroblast, NHF)와 인간 각질세포(human keratinocyte cell, HKC)에서의 세포독성을 확인한 결과, 특히 B16 멜라노마 세포에서 우수한 활성을 보였던 실시예 3의 추출물(에틸아세테이트 분획)에서는 세포독성도 없어 앞으로 이를 이용한 기능성 화장품 소재개발에 유용하리라 사료된다.
As shown in Tables 2, 3, 4 and 5 and FIGS. 1, 2 and 3, cytotoxicity of human fibroblast (NHF) and human keratinocyte (HKC) The extract of Example 3 (ethyl acetate fraction), which showed excellent activity in B16 melanoma cells, is not cytotoxic and may be useful for the development of functional cosmetic materials using the same in the future.

<< 실시예Example 10> 본 발명인  10> 비양나무Illiterate tree 추출물의 염증 유발인자인 NO( The inflammation inducer of the extract, NO ( NitricNitric oxideoxide )저해 효과 측정 실험) Inhibition effect measurement experiment

1. 실험방법1. Experimental Method

24 well plate에 3 × 105 cells/mL이 되도록 세포를 분주하고, 37℃의 5% CO2 조건하에서 18 h 배양 후 배지를 제거하고, D-phosphate buffered saline(D-PBS)으로 세척한 후 1μM LPS를 포함하는 배지로 교환 후 시료 추출물(실시예 1,2,3,4,5)을 농도별로 각각 첨가하여 1일간 배양하였다. Cells were seeded at a density of 3 × 10 5 cells / mL in a 24-well plate and cultured for 18 h at 37 ° C in 5% CO 2. After the medium was removed, the cells were washed with D-phosphate buffered saline (D-PBS) After exchanging with medium containing 1 [mu] M LPS, sample extracts (Examples 1, 2, 3, 4, and 5) were added for each concentration and cultured for 1 day.

1일 동안 배양 후 배지 100 ㎕에 그리스 시약(Griess reagent) 100 ㎕를 넣어 NO(Nitric oxide)를 측정하였고, 남은 배지 900 ㎕에 MTT 90 ㎕를 넣어 세포독성을 확인하였다.After culturing for 1 day, 100 μl of Griess reagent was added to 100 μl of culture medium to measure NO (nitric oxide), and 90 μl of MTT was added to the remaining medium to confirm cytotoxicity.

이는 microplate reader기로 각각 540 nm, 570 nm에서 흡광도를 측정하였다.
The absorbance was measured at 540 nm and 570 nm using a microplate reader.

2. 실험결과2. Experimental results

상기 실험결과를 아래의 표 6, 7과 도 4에 나타내었다.
The results of the above experiment are shown in Tables 6 and 7 and FIG.

처리농도
(㎍/ml)
Treatment concentration
(占 퐂 / ml)
NO 저해율
(%)
NO inhibition rate
(%)
세포 생존율
(%)
Cell survival rate
(%)
ControlControl 100100 00 100100 실시예 1(EtOH)Example 1 (EtOH) 100100 30.830.8 70.670.6 실시예 2(Hex)Example 2 (Hex) 100100 51.151.1 75.375.3 실시예 3(EtOAc)Example 3 (EtOAc) 100100 80.580.5 144.0144.0 실시예 4(BuOH)Example 4 (BuOH) 100100 27.827.8 94.594.5 실시예 5(water)Example 5 (water) 100100 10.610.6 100.5100.5

처리농도
(㎍/ml)
Treatment concentration
(占 퐂 / ml)
NO 저해율
(%)
NO inhibition rate
(%)
세포 생존율
(%)
Cell survival rate
(%)
ControlControl 100100 00 100100 실시예 3(EtOAc)Example 3 (EtOAc) 12.5
25
50
100
12.5
25
50
100
-4.7
16.5
47.6
77.4
-4.7
16.5
47.6
77.4
118.2
122.6
139.4
149.2
118.2
122.6
139.4
149.2

상기 표 6, 7과 도 4에 나타나 있듯이, RAW 264.7 cell에서의 NO(Nitric oxide)저해 효과를 확인한 결과, 실시예 3의 추출물(에틸아세테이트 분획)에서 NO저해 효과가 우수하였다.As shown in Tables 6 and 7 and FIG. 4, the inhibitory effect of NO (nitric oxide) on RAW 264.7 cells was confirmed. As a result, the NO inhibitory effect was excellent in the extract of Example 3 (ethyl acetate fraction).

Claims (6)

비양나무(Oreocnide fruticosa) 추출물을 유효성분으로 포함하는 화장료 조성물.A cosmetic composition comprising an extract of Oreocnide fruticosa as an active ingredient. 제1항에 있어서,
상기 비양나무 추출물은 피부주름개선 효과를 갖는 것을 특징으로 하는 화장료 조성물.
The method of claim 1,
The beech extract is a cosmetic composition, characterized in that it has a skin wrinkle improvement effect.
제1항에 있어서,
상기 비양나무 추출물은 항산화활성을 갖는 것을 특징으로 하는 화장료 조성물.
The method of claim 1,
The cosmetic composition according to claim 1, wherein the extract has an antioxidative activity.
제1항에 있어서,
상기 비양나무 추출물은 피부미백 효과를 갖는 것을 특징으로 하는 화장료 조성물.
The method of claim 1,
The cosmetic composition of claim 1, wherein the extract has a skin whitening effect.
제1항에 있어서,
상기 비양나무 추출물은 항염활성을 갖는 것을 특징으로 하는 화장료 조성물.
The method of claim 1,
The cosmetic composition according to claim 1, wherein the extract has a anti-inflammatory activity.
제1항에 있어서,
상기 비양나무 추출물은 화장료 조성물 전체중량 대비 0.0001 내지 10.0 중량 % 포함되는 것을 특징으로 하는 화장료 조성물.
The method of claim 1,
The cosmetic composition according to claim 1, wherein the composition comprises 0.0001 to 10.0% by weight of the total composition of the cosmetic composition.
KR1020120085669A 2012-08-06 2012-08-06 Cosmetic composition containing Oreocnide fruticosa extraction KR101441190B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020120085669A KR101441190B1 (en) 2012-08-06 2012-08-06 Cosmetic composition containing Oreocnide fruticosa extraction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120085669A KR101441190B1 (en) 2012-08-06 2012-08-06 Cosmetic composition containing Oreocnide fruticosa extraction

Publications (2)

Publication Number Publication Date
KR20140019536A true KR20140019536A (en) 2014-02-17
KR101441190B1 KR101441190B1 (en) 2014-09-18

Family

ID=50266962

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120085669A KR101441190B1 (en) 2012-08-06 2012-08-06 Cosmetic composition containing Oreocnide fruticosa extraction

Country Status (1)

Country Link
KR (1) KR101441190B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160008061A (en) 2014-07-11 2016-01-21 주식회사 엘지생활건강 Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing Melandrii Herba extracts

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102300580B1 (en) 2014-10-31 2021-09-10 주식회사 엘지생활건강 Cosmetic compositions comprising a Vin Chaud extract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3628196B2 (en) * 1999-01-08 2005-03-09 三井化学株式会社 Antioxidant and composition containing the same
JP3827581B2 (en) * 2002-01-31 2006-09-27 丸善製薬株式会社 Skin cosmetics and beauty food and drink
JP4530832B2 (en) * 2004-12-17 2010-08-25 株式会社資生堂 Skin external preparation for whitening, whitening agent, whitening method, and method for producing skin external preparation for whitening
JP2011105644A (en) * 2009-11-17 2011-06-02 Maruzen Pharmaceut Co Ltd Melanin uptake inhibitor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160008061A (en) 2014-07-11 2016-01-21 주식회사 엘지생활건강 Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing Melandrii Herba extracts

Also Published As

Publication number Publication date
KR101441190B1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
KR102047234B1 (en) Composition for Improving Skin Conditions with Improved Skin Whitening, Antioxidant, Moisturizing, Anti-wrinkling, and Regeneration Property Comprising Callus Extract of Hibiscus Syriacus
KR101506505B1 (en) Cosmetic composition comprising the extract of Golden silkworm cocoon as active ingredient
KR101885195B1 (en) Cosmetic Composition with Fermentative Extract of Osmanthus fragrans
KR20150143375A (en) Anti-wrinkle cosmetic composition comprising essentially Polygonum multiflorum adventitious extract
KR102373899B1 (en) Multifunctional cosmetic composition containing complex natural extracts effective for skin wrinkle improvement, whitening, cell regeneration, and wound healing as an active ingredient
KR100851489B1 (en) Cosmetic composition containing tilianin or acacetin
KR101204858B1 (en) Cosmetic Composition for for improving Skin-Wrinkle
KR20170055172A (en) Cosmetic Composition Comprising Extracts of Centipeda minima
KR101872357B1 (en) Cosmetic composition for enhancing skin elasticity containing extract of rhamnus yoshinoi
KR102350857B1 (en) Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water
KR100954695B1 (en) Cosmetic Composition Comprising the Extract of Abelliophyllum distichum as active Ingredient
KR101441190B1 (en) Cosmetic composition containing Oreocnide fruticosa extraction
KR102261149B1 (en) Compositions containing Gastrodia extracts
KR101995557B1 (en) Cosmetic composition including fermented water lily extract and method for manufacturing the same
KR20140130277A (en) Composition of skin external application comprising glycoprotein
KR101883310B1 (en) Cosmetic composition for improving skin wrinkle containing extract of rhamnus yoshinoi
KR20140089305A (en) Composition for improving skin whitening or skin wrinkle comprising extracts of Quercus salicina Blume
KR102119511B1 (en) Functional cosmetic composition
KR20210144725A (en) Anti-aging, antioxidant, anti-inflammatory and whitening agents, and cosmetics
KR101317433B1 (en) The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage
KR101957435B1 (en) Method for preparing extract of fermented silkworm cocoon for improving antiwrinkle and a cosmetic composition containing the fermented extract of silkworm cocoon as an active ingredients
KR101100129B1 (en) Cosmetic composition included neolitsea aciculata extraction
KR20010018668A (en) A cosmetic composition containing Cinnamomi Cortex extracts
JPH11147833A (en) Collagenase inhibitor
KR20190125005A (en) Cosmetic composition comprising upland rice fermented extracts

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
FPAY Annual fee payment

Payment date: 20170904

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20180906

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20190829

Year of fee payment: 6